未分化リンパ腫キナーゼ(ALK)遺伝子変異のある非小細胞肺がんに対する標的治療 https://t.co/u9TgAUt5Sz
RT @cameroncologist: https://t.co/rKzamrrNCV This took a long time to complete. Grateful for awesome co-authors.
RT @cameroncologist: https://t.co/rKzamrrNCV This took a long time to complete. Grateful for awesome co-authors.
RT @MDuruisseaux: Excellent systematic review about ALK TKI efficacy in ALK+ NSCLC. @CochraneLibrary Thanks to stellar team @bensolomon1 ht…
RT @MDuruisseaux: Excellent systematic review about ALK TKI efficacy in ALK+ NSCLC. @CochraneLibrary Thanks to stellar team @bensolomon1 ht…
RT @MDuruisseaux: Excellent systematic review about ALK TKI efficacy in ALK+ NSCLC. @CochraneLibrary Thanks to stellar team @bensolomon1 ht…
Excellent systematic review about ALK TKI efficacy in ALK+ NSCLC. @CochraneLibrary Thanks to stellar team @bensolomon1 https://t.co/ZykzgcW2xU
This is a great review . Pitty Australia does not have a national Lung Registry so authors "could interpret the influence of individual patient characteristics such as gender, age, ethnicity, or smoking status on outcomes "
RT @cameroncologist: https://t.co/rKzamrrNCV This took a long time to complete. Grateful for awesome co-authors.
RT @bensolomon1: Well done @cameroncologist and transTasman team on publishing this important work @cochranecollab Targeted therapy for adv…
Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer - Cameron, LB - 2022 | Cochrane Library https://t.co/S7pHc8EH1J
Must read, really great!
Targeted therapy for advanced anaplastic lymphoma kinase (<I>ALK</I>)-rearranged non-small cell lung cancer #lymphoma #lymsm https://t.co/qOBgcscWEJ
RT @cameroncologist: https://t.co/rKzamrrNCV This took a long time to complete. Grateful for awesome co-authors.
Well done @cameroncologist and transTasman team on publishing this important work @cochranecollab Targeted therapy for advanced anaplastic lymphoma kinase (ALK)‐rearranged non‐small cell lung cancer - Cameron, LB - 2022 | Cochrane Library
https://t.co/rKzamrrNCV This took a long time to complete. Grateful for awesome co-authors.